Ipatia Emframidou
Directeur/Membre du Conseil chez Colonis Pharma Ltd.
Profil
Ipatia Emframidou has worked as a Director at Colonis Pharma Ltd.
since 2017.
Postes actifs de Ipatia Emframidou
Sociétés | Poste | Début |
---|---|---|
Colonis Pharma Ltd.
Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Directeur/Membre du Conseil | 11/08/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Colonis Pharma Ltd.
Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Health Technology |